DISTINCT MONOCYTE GENE-EXPRESSION PROFILES IN Autoimmune DIABETES

  1. R.C. Padmos1,
  2. N.C. Schloot2,5,
  3. H. Beyan3,
  4. C. Ruwhof1,
  5. F.J.T. Staal1,
  6. D. de Ridder4,
  7. H-J. Aanstoot1,
  8. W-K. Tse1,
  9. H. de Wit1,
  10. C. Herder2,
  11. R.C. Drexhage (h.drexhage{at}erasmusmc.nl)1,
  12. B. Menart2,
  13. R.D. Leslie3,5 and
  14. H.A. Drexhage1
  1. From the Department of Immunology, Erasmus MC, Rotterdam, the Netherlands1
  2. German Diabetes Center, Düsseldorf, Germany2
  3. St Bartholomews Hospital, London, UK3
  4. Delft University of Technology, Delft, The Netherlands4
  5. For the Action LADA consortium5

    Abstract

    Objective: There is evidence that monocytes of patients with type 1 diabetes (T1D) show pro-inflammatory activation and disturbed migration/adhesion, but the evidence is inconsistent. Our hypothesis is that monocytes are distinctly activated/disturbed in different sub forms of autoimmune diabetes.

    Research Design and Methods: We studied patterns of inflammatory gene expression in monocytes of patients with T1D (juvenile, n=30, and adult, n=30, onset) and latent autoimmune diabetes of the adult (LADA) (n=30) (controls: healthy subjects, n=49, type 2 diabetes patients, n=30) using quantitative-PCR (Q-PCR). We tested 25 selected genes: 12 genes detected in a pre-study via whole genome analyses plus an additional 13 genes identified as part of a monocyte inflammatory signature previously reported.

    Results: We identified two distinct monocyte gene-expression clusters in autoimmune diabetes. One cluster (comprising 12 pro-inflammatory cytokine/compound genes with a putative key gene PDE4B) was detected in LADA (60%) and adult-onset T1D (28%), but in only 10% juvenile-onset T1D. A second cluster (comprising 10 chemotaxis, adhesion, motility and metabolism genes) was detected in juvenile-onset T1D (43%) and LADA (33%) but in only 9% adult-onset T1D.

    Conclusions: Sub-groups of T1D patients show an abnormal monocyte gene expression with two profiles, supporting a concept of heterogeneity in the pathogenesis of immune-mediated diabetes only partly overlapping with the presently known diagnostic categories.

    Footnotes

      • Received April 11, 2008.
      • Accepted June 21, 2008.